Oppenheimer & Co. Inc. Sells 1,156 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Oppenheimer & Co. Inc. lessened its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 16,910 shares of the company’s stock after selling 1,156 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Myriad Genetics were worth $232,000 as of its most […]
Oppenheimer & Co. Inc. lessened its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 16,910 shares of the company’s stock after selling 1,156 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Myriad Genetics were worth $232,000 as of its most […]
